The estimated Net Worth of Michael Cammarata is at least $58.8 Milion dollars as of 27 December 2022. Mr. Cammarata owns over 87,289 units of Neptune Wellness Solutions Inc stock worth over $99,372 and over the last 3 years he sold NEPT stock worth over $0. In addition, he makes $58,743,200 as President, Chief Executive Officer oraz Director at Neptune Wellness Solutions Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Cammarata NEPT stock SEC Form 4 insiders trading
Michael has made over 5 trades of the Neptune Wellness Solutions Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 87,289 units of NEPT stock worth $17,458 on 27 December 2022.
The largest trade he's ever made was exercising 3,132,900 units of Neptune Wellness Solutions Inc stock on 2 May 2022 worth over $626,580. On average, Michael trades about 1,290,613 units every 54 days since 2022. As of 27 December 2022 he still owns at least 496,858 units of Neptune Wellness Solutions Inc stock.
You can see the complete history of Mr. Cammarata stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Cammarata biography
Michael Taylor Cammarata serves as President, Chief Executive Officer, Director of the Company. Mr. Cammarata is the founder of Random Occurrence, a venture capital and private equity firm. He invested in and cofounded Schmidt’s Naturals, one of the world’s fastest growing wellness brands, leading it from fledgling start-up to acquisition in 2017 by Unilever and onto record breaking growth in 2018. He remained CEO of Schmidt’s Naturals until June 2019, leading its rapid expansion into new and innovative products, retailers and global markets. Mr. Cammarata is a new breed of unconventional CEO with a personal mission to invest and scale companies globally that will make sustainable innovation and modern wellness solutions accessible to the world. He believes that natural products are the future and that every person deserves natural products that work and minimize their harm to people, the planet and animals. With Schmidt’s and other investments, Mr. Cammarata is looking toward future technologies, including AI and machine learning to create stronger connections and personalized products for customers. He is a passionate advocate for ending animal testing and refuses to sell Schmidt’s products in China until they end their animal testing requirements. Raised in New York, his dyslexia made school challenging, but that perspective allowed him to identify opportunities others missed. He became a technology and marketing wunderkind by his mid-teens. He rapidly gained a reputation as an innovative entrepreneur, creating $85 million in revenue by his twenties.
What is the salary of Michael Cammarata?
As the President, Chief Executive Officer oraz Director of Neptune Wellness Solutions Inc, the total compensation of Michael Cammarata at Neptune Wellness Solutions Inc is $58,743,200. There are no executives at Neptune Wellness Solutions Inc getting paid more.
What's Michael Cammarata's mailing address?
Michael's mailing address filed with the SEC is C/O NEPTUNE WELLNESS SOLUTIONS INC. 100-, 545 PROMENADE DU CENTROPOLIS, LAVAL, A8, H7T 0A3.
Insiders trading at Neptune Wellness Solutions Inc
Over the last 3 years, insiders at Neptune Wellness Solutions Inc have traded over $648,862 worth of Neptune Wellness Solutions Inc stock. The most active insiders traders include Michael Cammarata, Securities Settlement Fund ... oraz Raymond Silcock. On average, Neptune Wellness Solutions Inc executives and independent directors trade stock every 58 days with the average trade being worth of $121,241. The most recent stock trade was executed by Securities Settlement Fund ... on 1 March 2024, trading 81,814 units of NEPT stock currently worth $35,180.
What does Neptune Wellness Solutions Inc do?
vision: provide great products and solutions that deliver optimal health and wellness. mission: leverage our scientific and innovative expertise to create and provide our customers globally with the best nutritional products and wellness solutions. neptune is active in five main areas: cannabis business: neptune is working to develop unique extracts and formulations in the legal cannabis wellness field. ingredients: leveraging our global network of suppliers, we source a variety of marine oils, seed oils and specialty ingredients. turnkey solutions: we develop product concepts in collaboration with our customers (branded marketers) as turnkey finished supplements that are ready for sale under their brand, primarily as softgels, capsules, liquids and powders. through our global network of suppliers, we source ingredients and formulate the ideal product. the ingredients are sent to third-party manufacturers, where the formula is developed in a liquid, powder or capsule form and then pack
What does Neptune Wellness Solutions Inc's logo look like?
Complete history of Mr. Cammarata stock trades at Neptune Wellness Solutions Inc
Neptune Wellness Solutions Inc executives and stock owners
Neptune Wellness Solutions Inc executives and other stock owners filed with the SEC include:
-
Michael Cammarata,
President, Chief Executive Officer, Director -
Graham Wood,
Chief Scientific Officer -
Jacqueline Khayat,
Vice President, Business Development – Cannabis Business -
Dr. Toni Rinow MBA., Ph.D.,
Chief Operating Officer -
Michel Timperio,
President - Cannabis Business -
Jean-Daniel Belanger,
Vice President, Legal Affairs & Corporate Secretary -
Russel Jay,
VP of Sales in USA -
Toni Rinow,
Chief Financial Officer, Vice President -
Christopher Piazza,
Sr. Legal Counsel & Assistant Corp. Sec. -
John Moretz,
Independent Chairman of the Board -
Scott Winkle,
Investor Relations -
Richard Schottenfeld,
Independent Director -
Ronald Denis,
Independent Director -
Michael De Geus,
Independent Director -
Joseph Buaron,
Independent Director -
Russell Jay,
Vice President of U.S. Sales -
Robert Dipede,
Senior Vice President of Biodroga and Health & Wellness Innovation -
David Mayers,
Chief Operating Officer -
Marc Vaugeois,
VP of Sales -
Morry Brown,
VP of Investor Relations -
Jessica Adkins,
Sr. VP of Corp. Communications -
Gary S. Kaminsky,
Sr. VP of Compliance & Legal Affairs -
John Wirt,
Gen. Counsel -
Steve Wayne West,
VP of Investor Relations -
Randy Weaver,
Interim Chief Financial Officer -
Roger Corriveau,
Vice-Pres of Bus. Devel. -
Sabrina Di Blasio,
Director of Marketing & Communications -
Jean-Daniel Bélanger,
VP of Legal Affairs & Corp. Sec. -
John Ripplinger,
Director of Investor Relations -
Stephen Lijoi,
VP Operations -
James S. Hamilton,
Advisor -
Securities Settlement Fund ...,
10% owner -
Philip H Sanford,
Director -
Raymond Silcock,
Chief Financial Officer